Montes Archimedes Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $410.72M
IPO Date Oct 7, 2020
CEO James C. Momtazee
Left Lead Citigroup
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company Roivant Sciences
Deal Announced May 3, 2021
Deal Size, $M $5,000.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Sep 28, 2021
Amendment Vote TBD
Closing Date Sep 30, 2021
Formerly MAAC ROIV ROIVW

Sign up for Free Trial

No credit card required

Sign in for more on Montes Archimedes Acquisition Corp.:

  • Structure and cap table
  • 4 directors & officers
  • 25 filings and events
  • 2 underwriters
  • 9 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
James C. Momtazee 48 CEO and Director
Maria C. Walker 55 CFO
George Barrett 65 Director
Steve Oesterle 69 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Citigroup Joint BR 26,000,000 units
Jefferies Joint BR 14,000,000
40,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 25 filings.

Shareholders

Sign in to view shareholders 13F filing data.